StockData
Centene Corp logo

Centene Corp (CNC) company profile

CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 8/302% above fair value
$71.27+1.00 (+1.42%)

Close on Nov 13, 2026Market cap $35.28BP/E 24.4Yield –

About Centene

Hospital & Medical Service Plans, SIC 6324

Centene Corporation is a managed healthcare enterprise that delivers health insurance and specialized clinical solutions primarily to underinsured and low-income populations. Operating across Medicaid, Medicare, Commercial, and Other business lines, the company provides government-sponsored programs including Medicaid expansion, Temporary Assistance for Needy Families, and Children’s Health Insurance Programs. It also delivers Medicare Advantage, Medicare Part D prescription drug coverage, and individual marketplace health insurance plans. Supplementary services include specialty pharmacy administration, behavioral health, dental, vision, and outpatient primary care. Centene serves low-income families, elderly individuals, individuals with disabilities, and commercial health insurance customers.

The company maintains an extensive domestic presence across the United States, managing health programs in multiple states and regions. It administers Medicaid services across 30 states, Medicare Advantage plans in 32 states, and individual marketplace insurance coverage throughout 29 states. In addition, its standalone prescription drug coverage extends across all 50 states and the District of Columbia. The enterprise operates through a decentralized community-focused model supported by a national corporate infrastructure. Centene does not specify its corporate headquarters city in the provided text.

Summary of the business section of Centene's latest annual report, written by StockData.

Company profile

Company

Legal name
Centene Corp
Founded
1984
Headquarters
St Louis, MO
Address
7700 Forsyth Blvd. 63105
Phone
(314) 725-4477
Employees
61,100, Dec 31, 2025
Industry
Hospital & Medical Service Plans
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, St. Louis, MO

Stock & identifiers

Ticker
CNC
Exchange
NYSE
IPO date
Dec 13, 2001
Shares outstanding
495M, Oct 23, 2026
Public float
$26.70B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Feb 7, 2019; 2-for-1, Feb 20, 2015; 2-for-1, Dec 20, 2004; 3-for-2, Jul 14, 2003
SEC CIK
1071739
CUSIP
15135B101
ISIN
US15135B1017
FIGI
BBG000BDXCJ5
Share class FIGI
BBG001S6T7Q8
LEI
549300Z7JJ4TQSQGT333
EIN
04-1406317

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Sarah LondonChief Executive Officer, Director1,188,831
Michael A. CarsonGroup President, Medicare&Spec116,577
Theodore J. PienkosCorporate Controller & CAO28,751
Christopher KosterSecretary & General Counsel248,954
Susan Raye SmithChief Operating Officer212,237
Daniel P. FinkeGroup President, Markets&Comm228,127
Tanya M. McNallyChief People Officer127,258
Andrew Lynn AsherChief Financial Officer747,989
Katie CassoCorporate Controller & CAO109,776
Lauren M. TylerDirector3,698
Christopher J. CoughlinDirector49,348
Kenneth TanjiDirector13,093
Frederick H. EppingerDirector370,402
Theodore R. Samuels IIDirector57,796
Paul J. DiazDirector0
Kenneth A. BurdickDirector283,584
Jessica L. BlumeDirector32,607
H. James DallasDirector49,567
Monte E. FordDirector14,827
Wayne S. DeVeydtDirector19,523
Thomas GrecoDirector22,888

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
London
$19.51M$4.65M$7.66M$69$148
FY2025
Neidorff
$0$0$7.66M$69$148
FY2024
London
$20.60M$5.38M$7.20M$101$129
FY2024
Neidorff
$0$0$7.20M$101$129
FY2023–$13.97M$7.57M$124$126
FY2023
London
$18.56M$13.97M$7.57M$124$126

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Sarah M. London
Chief Executive Officer
$1.47M$15.54M$2.11M$386.04K$19.51M-5%
Andrew L. Asher
Chief Financial Officer
$1.15M$13.36M$1.24M$318.87K$16.07M+44%
Christopher A. Koster
Secretary and General Counsel
$768.27K$5.11M$550.08K$79.36K$6.51M+29%
Tanya McNally
Chief People Officer
$654.81K$1.97M$468.84K$80.95K$3.17M–
Susan R. Smith
Chief Operating Officer
$718.27K$3.58M$514.28K$76.75K$4.89M+39%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 61,100 team members.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?